Amin is the Director of the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester. In 2007, whilst working at the University of Sheffield, he became the first full Professor appointed with the title of "Systems Pharmacology". Professor Rostami has authored/co-authored over 230 highly cited articles (>11,000 citations, H-Factor >55) and in 2017 he was enlisted by ISI as one of the most highly cited researchers in the world (under the category of ‘Pharmacology & Toxicology’). Amin was a founding editor of Pharmacometrics and System Pharmacology (CPT:PSP) and has been serving on the Editorial Boards of several other clinical pharmacology and drug metabolism journals over many years. Professor Rostami is renowned for his contribution to translational modelling (e.g. PBPK) and has been an invited speaker at over 180 international and national meetings, in addition to leading numerous workshops in the area of IVIVE- PBPK linked models.
Professor Rostami has an active program of training PhD students involving proteomics, PBPK, clinical PKPD and precision dosing. Many graduates from his team hold positions in the pharmaceutical industry or academia.
As a co-founder of Simcyp Limited (a University of Sheffield spin-off acquired by Certara) he is part-time secondee at Certara. As its Chief Scientific Officer he ensures that the latest scientific advances in the field of biosimulation are incorporated into all of the drug development efforts by various pharmaceutical companies. Certara is the largest company focused on Modellling and Simulation as well as Regulatory Strategy in the space of pharmaceutical industry.